Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Elevance Health, Inc. (ELV)
:ELV
ELV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$362.21 - $567.26
Previous CloseN/A
Volume477.50K
Average Volume (3M)1.63M
Market Cap
$88.71B
Enterprise Value$116.60B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)14.9
Beta0.30
Next Earnings
Apr 16, 2025EPS Estimate
10.62Next Dividend Ex-Date
Mar 10, 2025Dividend Yield1.7%
Share Statistics
EPS (TTM)25.61
Shares Outstanding231,922,820
10 Day Avg. Volume1,252,991
30 Day Avg. Volume1,633,934
Standard Deviation0.08
R-Squared0.32
Alpha0.00071
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.52
Price to Cash Flow (P/CF)8.50
P/FCF Ratio7.80
Enterprise Value/Market Cap1.31
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.74
Enterprise Value/Ebitda12.76
Forecast
1Y Price Target
$472.38Price Target Upside20.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
---
Bulls Say, Bears Say
Bulls Say
EarningsELV reported slightly better results than feared with adjusted EPS of $3.84 beating consensus of $3.81 by nearly 1%.
Medicare Advantage GrowthElevance Health expects to achieve 7 to 9% growth in Medicare Advantage through strong member retention and contract wins.
ValuationELV's valuation remains very inexpensive (both absolute and relative) vs. history, hovering at decade lows.
Bears Say
Medicaid ChallengesMedicaid challenges are pressuring the cost trend, with core MLR increasing 290bps year-over-year.
Risk Premium MarginsExcluding Carebridge and Caremore, Risk Premium margins are down ~600bp over 2 years, with pressure in risk arrangements and Medicaid pressure being main culprits.
Segment RevenueHealth benefits segment revenue of $37.58 billion missed the estimate by 2.3% with segment earnings missing the estimate by nearly 25%.
---
Ownership Overview
0.12% Insiders
25.37% Mutual Funds
26.02% Other Institutional Investors
26.65% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Ability to SellRisks related to the company’s ability to sell goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ELV FAQ
What was Elevance Health, Inc.’s price range in the past 12 months?
Elevance Health, Inc. lowest stock price was $362.21 and its highest was $567.26 in the past 12 months.
What is Elevance Health, Inc.’s market cap?
Elevance Health, Inc.’s market cap is $88.71B.
When is Elevance Health, Inc.’s upcoming earnings report date?
Elevance Health, Inc.’s upcoming earnings report date is Apr 16, 2025 which is in 53 days.
How were Elevance Health, Inc.’s earnings last quarter?
Elevance Health, Inc. released its earnings results on Jan 23, 2025. The company reported $3.84 earnings per share for the quarter, missing the consensus estimate of $4.013 by -$0.173.
Is Elevance Health, Inc. overvalued?
According to Wall Street analysts Elevance Health, Inc.’s price is currently Undervalued.
Does Elevance Health, Inc. pay dividends?
Elevance Health, Inc. pays a Quarterly dividend of $6.52 which represents an annual dividend yield of 1.7%. See more information on Elevance Health, Inc. dividends here
What is Elevance Health, Inc.’s EPS estimate?
Elevance Health, Inc.’s EPS estimate is 10.62.
How many shares outstanding does Elevance Health, Inc. have?
Elevance Health, Inc. has 231,922,820 shares outstanding.
What happened to Elevance Health, Inc.’s price movement after its last earnings report?
Elevance Health, Inc. reported an EPS of $3.84 in its last earnings report, missing expectations of $4.013. Following the earnings report the stock price went up 2.721%.
Which hedge fund is a major shareholder of Elevance Health, Inc.?
Currently, no hedge funds are holding shares in ELV
---
Elevance Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$472.38 (20.97% Upside)
$472.38 (20.97% Upside)
Blogger Sentiment
Bullish
ELV Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 11.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.4%
Last 30 Days ▲ 2.0%
Last 30 Days ▲ 2.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.23%
12-Months-Change
Fundamentals
Return on Equity
14.83%
Trailing 12-Months
Asset Growth
7.11%
Trailing 12-Months
Company Description
Elevance Health, Inc.
Indiana-based Anthem, Inc. was formed in 2004 after the merger of WellPoint Health Networks Inc. and Anthem, Inc. The company is one of the leading health insurance names, and provides medical benefits through a range of integrated healthcare plans and related services, along with a wide range of specialty products such as life and disability insurance benefits, dental, vision, behavioral health benefit services, as well as long-term care insurance and flexible spending accounts.
---
ELV Company Deck
---
ELV Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed sentiment with strong growth in Medicare Advantage and commercial businesses, alongside challenges in Medicaid cost trends and membership reductions. The company is confident in navigating these challenges and executing growth strategies.Read More>---
ELV Stock 12 Month Forecast
Average Price Target
$472.38
▲(20.97% Upside)
Technical Analysis
Best Analysts Covering ELV
1 Year
---